ClinConnect ClinConnect Logo
Search / Trial NCT01137825

Registry of Older Patients With Cancer

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jun 3, 2010

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cognitive/Functional Effects Unspecified Adult Solid Tumor, Protocol Specific Accelerated Phase Chronic Myelogenous Leukemia Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia In Remission Adult Acute Myeloid Leukemia In Remission Adult Acute Myeloid Leukemia With 11q23 (Mll) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(P13;Q22) Adult Acute Myeloid Leukemia With T(15;17)(Q22;Q12) Adult Acute Myeloid Leukemia With T(16;16)(P13;Q22) Adult Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Atypical Chronic Myeloid Leukemia, Bcr Abl Negative Blastic Phase Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Mast Cell Leukemia Meningeal Chronic Myelogenous Leukemia Progressive Hairy Cell Leukemia, Initial Treatment Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult T Cell Leukemia/Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Stage 0 Chronic Lymphocytic Leukemia Stage I Adult T Cell Leukemia/Lymphoma Stage I Chronic Lymphocytic Leukemia Stage Ii Adult T Cell Leukemia/Lymphoma Stage Ii Chronic Lymphocytic Leukemia Stage Iii Adult T Cell Leukemia/Lymphoma Stage Iii Chronic Lymphocytic Leukemia Stage Iv Adult T Cell Leukemia/Lymphoma Stage Iv Chronic Lymphocytic Leukemia T Cell Large Granular Lymphocyte Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Hairy Cell Leukemia Recurrent Adult Hodgkin Lymphoma Stage I Adult Hodgkin Lymphoma Stage Ii Adult Hodgkin Lymphoma Stage Iii Adult Hodgkin Lymphoma Stage Iv Adult Hodgkin Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T Cell Lymphoma Cutaneous B Cell Non Hodgkin Lymphoma Recurrent Cutaneous T Cell Non Hodgkin Lymphoma Stage I Cutaneous T Cell Non Hodgkin Lymphoma Stage Ii Cutaneous T Cell Non Hodgkin Lymphoma Stage Iii Cutaneous T Cell Non Hodgkin Lymphoma Stage Iv Cutaneous T Cell Non Hodgkin Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Stage I Mycosis Fungoides/Sezary Syndrome Stage Ii Mycosis Fungoides/Sezary Syndrome Stage Iii Mycosis Fungoides/Sezary Syndrome Stage Iv Mycosis Fungoides/Sezary Syndrome Adult Grade Iii Lymphomatoid Granulomatosis Adult Nasal Type Extranodal Nk/T Cell Lymphoma Waldenstrom Macroglobulinemia Extranodal Marginal Zone B Cell Lymphoma Of Mucosa Associated Lymphoid Tissue Nodal Marginal Zone B Cell Lymphoma Splenic Marginal Zone Lymphoma Contiguous Stage Ii Adult Burkitt Lymphoma Contiguous Stage Ii Adult Diffuse Large Cell Lymphoma Contiguous Stage Ii Adult Diffuse Mixed Cell Lymphoma Contiguous Stage Ii Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage Ii Adult Immunoblastic Large Cell Lymphoma Contiguous Stage Ii Adult Lymphoblastic Lymphoma Contiguous Stage Ii Grade 1 Follicular Lymphoma Contiguous Stage Ii Grade 2 Follicular Lymphoma Contiguous Stage Ii Grade 3 Follicular Lymphoma Contiguous Stage Ii Mantle Cell Lymphoma Contiguous Stage Ii Marginal Zone Lymphoma Contiguous Stage Ii Small Lymphocytic Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Noncontiguous Stage Ii Adult Burkitt Lymphoma Noncontiguous Stage Ii Adult Diffuse Large Cell Lymphoma Noncontiguous Stage Ii Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage Ii Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage Ii Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage Ii Adult Lymphoblastic Lymphoma Noncontiguous Stage Ii Grade 1 Follicular Lymphoma Noncontiguous Stage Ii Grade 2 Follicular Lymphoma Noncontiguous Stage Ii Grade 3 Follicular Lymphoma Noncontiguous Stage Ii Mantle Cell Lymphoma Noncontiguous Stage Ii Marginal Zone Lymphoma Noncontiguous Stage Ii Small Lymphocytic Lymphoma Stage Iii Adult Burkitt Lymphoma Stage Iii Adult Diffuse Large Cell Lymphoma Stage Iii Adult Diffuse Mixed Cell Lymphoma Stage Iii Adult Diffuse Small Cleaved Cell Lymphoma Stage Iii Adult Immunoblastic Large Cell Lymphoma Stage Iii Adult Lymphoblastic Lymphoma Stage Iii Grade 1 Follicular Lymphoma Stage Iii Grade 2 Follicular Lymphoma Stage Iii Grade 3 Follicular Lymphoma Stage Iii Mantle Cell Lymphoma Stage Iii Marginal Zone Lymphoma Stage Iii Small Lymphocytic Lymphoma Stage Iv Adult Burkitt Lymphoma Stage Iv Adult Diffuse Large Cell Lymphoma Stage Iv Adult Diffuse Mixed Cell Lymphoma Stage Iv Adult Diffuse Small Cleaved Cell Lymphoma Stage Iv Adult Immunoblastic Large Cell Lymphoma Stage Iv Adult Lymphoblastic Lymphoma Stage Iv Grade 1 Follicular Lymphoma Stage Iv Grade 2 Follicular Lymphoma Stage Iv Grade 3 Follicular Lymphoma Stage Iv Mantle Cell Lymphoma Stage Iv Marginal Zone Lymphoma Stage Iv Small Lymphocytic Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade Iii Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Intraocular Lymphoma Post Transplant Lymphoproliferative Disorder Chronic Eosinophilic Leukemia Chronic Neutrophilic Leukemia Primary Myelofibrosis Essential Thrombocythemia Polycythemia Vera Extramedullary Plasmacytoma Isolated Plasmacytoma Of Bone Stage I Multiple Myeloma Stage Ii Multiple Myeloma Stage Iii Multiple Myeloma Primary Systemic Amyloidosis Refractory Multiple Myeloma De Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Secondary Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable

ClinConnect Summary

This clinical trial, called the Registry of Older Patients With Cancer, aims to collect important information about older adults who have cancer. The goal is to better understand how cancer affects this age group and to improve future cancer research. The study is currently looking for participants who are 23 years or older and have an appointment at the North Carolina Cancer Hospital. It’s important that participants can read and speak English, and they will need to agree to complete a Geriatric Assessment, which is a test that helps evaluate their overall health and abilities.

Participants in this study can expect to contribute their information to a registry, which will be used for research purposes. Even if someone is not ultimately diagnosed with cancer, they can still be part of the registry, but their information will be kept in a separate group. This trial is open to all genders, and it’s an opportunity for older patients to help advance our understanding of cancer and its impact on older adults.

Gender

ALL

Eligibility criteria

  • DISEASE CHARACTERISTICS:
  • Patients must have an appointment at the North Carolina Cancer Hospital and agree to complete the Geriatric Assessment NOTE: Not all patients included in the registry will ultimately be diagnosed with cancer. Patients who complete a GA and are not diagnosed with cancer will remain in the database, but will be categorized into a separate group and will not have their medical records accessed.
  • PATIENT CHARACTERISTICS:
  • Able to read and speak English
  • PRIOR CONCURRENT THERAPY:
  • Not specified

About Unc Lineberger Comprehensive Cancer Center

The UNC Lineberger Comprehensive Cancer Center is a leading research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and comprehensive patient care. As a National Cancer Institute-designated comprehensive cancer center, it integrates cutting-edge research, interdisciplinary collaboration, and patient-centered approaches to address diverse oncology challenges. With a commitment to translating scientific discoveries into effective therapies, UNC Lineberger strives to improve outcomes for patients while fostering a robust environment for education and training in cancer research.

Locations

Chapel Hill, North Carolina, United States

Raleigh, North Carolina, United States

Greenville, North Carolina, United States

Boone, North Carolina, United States

Hendersonville, North Carolina, United States

Morehead City, North Carolina, United States

New Bern, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Hyman Muss, MD

Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials